Incidence, trends, and predictors of ischemic stroke 1 year after an acute myocardial infarction

Stroke

Volumn 45, Issue 11, 2014, Pages 3263-3268

  Ulvenstam, Anders ^a,d   Kajermo, Ulf ^b,d   Modica, Angelo ^a,d   Jernberg, Tomas ^c   Söderström, Lars ^a   Mooe, Thomas ^d  

^a ÖSTERSUND HOSPITAL   (Sweden)

^b Skaraborgs hospital Skövde   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UMEÅ UNIVERSITY   (Sweden)

Author keywords

Cerebral infarction; Epidemiology; Risk factors

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; AGE; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; FEMALE; FEMININITY; FIBRINOLYSIS; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTOR VARIABLE; PRIORITY JOURNAL; REPERFUSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE PATIENT; EPIDEMIOLOGY; FACTUAL DATABASE; KAPLAN MEIER METHOD; MYOCARDIAL INFARCTION; PREDICTIVE VALUE; REGISTER; STROKE; SWEDEN; TRENDS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; DATABASES, FACTUAL; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; REGISTRIES; STROKE; SWEDEN;

EID: 84922479694     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005770     Document Type: Article

References (26)

1. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jönsson B; CDBE2010 Study Group; European Brain Council. The economic cost of brain disorders in Europe. Eur J Neurol. 2012;19:155-162.
2. Dutta M, Hanna E, Das P, Steinhubl SR. Incidence and prevention of ischemic stroke following myocardial infarction: review of current literature. Cerebrovasc Dis. 2006;22:331-339.
3. Budaj A, Flasinska K, Gore JM, Anderson FA Jr, Dabbous OH, Spencer FA, et al; GRACE Investigators. Magnitude of and risk factors for inhospital and postdischarge stroke in patients with acute coronary syndromes: findings from a Global Registry of Acute Coronary Events. Circulation. 2005;111:3242-3247.
4. Saczynski JS, Spencer FA, Gore JM, Gurwitz JH, Yarzebski J, Lessard D, et al. Twenty-year trends in the incidence of stroke complicating acute myocardial infarction: Worcester Heart Attack Study. Arch Intern Med. 2008;168:2104-2110.
5. Witt BJ, Brown RD Jr, Jacobsen SJ, Weston SA, Yawn BP, Roger VL. A community-based study of stroke incidence after myocardial infarction. Ann Intern Med. 2005;143:785-792.
6. Tanne D, Gottlieb S, Hod H, Reicher-Reiss H, Boyko V, Behar S. Incidence and mortality from early stroke associated with acute myocardial infarction in the prethrombolytic and thrombolytic eras. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) and Israeli Thrombolytic Survey Groups. J Am Coll Cardiol. 1997;30:1484-1490.
7. Witt BJ, Ballman KV, Brown RD Jr, Meverden RA, Jacobsen SJ, Roger VL. The incidence of stroke after myocardial infarction: a meta-analysis. Am J Med. 2006;119:354.e1-354.e9.
8. Mooe T, Eriksson P, Stegmayr B. Ischemic stroke after acute myocardial infarction. A population-based study. Stroke. 1997;28:762-767.
9. Kajermo U, Ulvenstam A, Modica A, Jernberg T, Mooe T. Incidence, trends, and predictors of ischemic stroke 30 days after an acute myocardial infarction. Stroke. 2014;45:1324-1330.
10. Albaker O, Zubaid M, Alsheikh-Ali AA, Rashed W, Alanbaei M, Almahmeed W, et al; Gulf RACE Investigators. Early stroke following acute myocardial infarction: incidence, predictors and outcome in six Middle-Eastern countries. Cerebrovasc Dis. 2011;32:471-482.
11. Stenestrand U, Wallentin L; Swedish Register of Cardiac Intensive Care (RIKS-HIA). Early statin treatment following acute myocardial infarction and 1-year survival. JAMA. 2001;285:430-436.
12. Janszky I, Ahnve S, Ljung R, Mukamal KJ, Gautam S, Wallentin L, et al. Daylight saving time shifts and incidence of acute myocardial infarction-Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA). Sleep Med. 2012;13:237-242.
13. Jernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A, et al. The Swedish Web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies (SWEDEHEART). Heart. 2010;96:1617-1621.
14. Köster M, Asplund K, Johansson Å, Stegmayr B. Refinement of Swedish administrative registers to monitor stroke events on the national level. Neuroepidemiology. 2013;40:240-246.
15. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450.
16. Sampson UK, Pfeffer MA, McMurray JJ, Lokhnygina Y, White HD, Solomon SD; VALIANT Trial Investigators. Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial. Eur Heart J. 2007;28:685-691.
17. Van de Graaff E, Dutta M, Das P, Shry EA, Frederick PD, Blaney M, et al. Early coronary revascularization diminishes the risk of ischemic stroke with acute myocardial infarction. Stroke. 2006;37:2546-2551
18. Isis-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: Isis-2. Lancet. 1988;2:349-360.
19. Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D, et al; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: The MIRACL study: a randomized controlled trial. JAMA. 2001;285:1711-1718.
20. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK; Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345:494-502.
21. Chen ZM, Jiang LX, Chen YP, Xie JX, Pan HC, Peto R, et al; COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative group. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005;366:1607-1621.
22. Sabatine MS, Cannon CP, Gibson CM, López-Sendón JL, Montalescot G, Theroux P, et al; CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179-1189.
23. Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al; PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008;359:1238-1251.
24. Wienbergen H, Schiele R, Gitt AK, Schneider S, Heer T, Gottwik M, et al; MIR and MITRA Study Groups. Myocardial Infarction Registry. Maximal Individual Therapy in Acute Myocardial Infarction. Incidence, risk factors, and clinical outcome of stroke after acute myocardial infarction in clinical practice. MIR and MITRA Study Groups. Myocardial Infarction Registry. Maximal Individual Therapy in Acute Myocardial Infarction. Am J Cardiol. 2001;87:782-785, A8.
25. Lewsey J, Jhund PS, Gillies M, Chalmers JW, Redpath A, Briggs A, et al. Temporal trends in hospitalisation for stroke recurrence following incident hospitalisation for stroke in Scotland. BMC Med. 2010;8:23.
26. Jernberg T. Swedeheart 2011 annual report. Uppsala, Sweden: Uppsala Clinical Research Center; 2011:16-17. http://www.ucr.uu.se/swedeheart/ index.php/dokument-sh/arsrapporter/cat-view/52-swedeheart/ 43-arsrapport-2012/41-arsrapport-2011. Accessed January 15, 2012.